Wall Street Stock Market & Finance report, prediction for the future: You'll find the Calliditas Therapeutics AB - ADR share forecasts, stock quote and buy / sell signals below. According to present data Calliditas Therapeutics AB - ADR's CALT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

Initial public offering of Calliditas Therapeutics AB (SE) on Nasdaq Stockholm of Port of Tallinn (EE) on Nasdaq Tallinn Stock Exchange — EUR 147 million.

Calliditas Therapeutics has filed to raise $75 million in a U.S. IPO, although the final figure may differ. The firm is advancing a small pipeline of drug candidates focused on treating kidney and Get instant access to a free live streaming chart of the Calliditas Therapeutics Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area, lines 2021-03-10 · View the latest Calliditas Therapeutics AB (CLTEF) stock price, news, historical charts, analyst ratings and financial information from WSJ. The Calliditas Therapeutics AB 52-week low stock price is 19.00, which is 31.1% below the current share price. The average Calliditas Therapeutics AB stock price for the last 52 weeks is 27.14 . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide .

Provide the latest Calliditas Therapeutics AB(CALT) market data, including prices , cycle charts, basic information and real-time news information, financial Calliditas Therapeutics AB ADR (CALT) Company Bio. Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. Next Event. Calliditas Therapeutics AB Annual Shareholders Meeting Jun 25, 2021 Total Debt To Equity (MRQ). 0.07. LT Debt To Equity (MRQ).

View live CALLIDITAS THERAPEUTICS AB chart to track its stock's price action. Find market predictions, CALTX financials and market news.

View analysts' price targets for Calliditas Therapeutics AB (publ) or view top-rated stocks among Wall Street analysts . Calliditas is focused on the development and commercialization of its 2021, at 07:00 CET, Calliditas Therapeutics published its year-end report for 2020. Report; In depth view into CALT (Calliditas Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.

2021-04-21 · Calliditas Therapeutics AB American Depositary Shares (CALT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously. 1 dag sedan · Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the U.S. Food and Drug Administration (FDA) has accepted the submission and granted Priority Review for the New Drug Application (NDA) for Nefecon, a down regulator of IgA1 for the treatment of IgA nephropathy (IgAN.) Wall Street Stock Market & Finance report, prediction for the future: You'll find the Calliditas Therapeutics AB - ADR share forecasts, stock quote and buy / sell signals below. According to present data Calliditas Therapeutics AB - ADR's CALT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Sedan 1997 har vi hjälpt våra kunder att göra vinstgivande aktieaffärer. Här hittar du färska aktietips, intervjuer, aktieanalyser och det senaste från aktiemarknaden. 1 dag sedan · Calliditas Therapeutics AB (publ) (NASDAQ:CALT) went up by 10.15% from its latest closing price compared to the recent 1-year high of $38.00.

Calliditas Therapeutics Stock Performance (As of Thursday Closing) Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; $13.70: $13.63: $8.80 - $19.22: $684M: 49.9M: 194K-$1.05: Calliditas Therapeutics Financials Summary.
Jonas eckhardt

Use the PitchBook Platform to explore the full Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. Provide the latest Calliditas Therapeutics AB(CALT) market data, including prices , cycle charts, basic information and real-time news information, financial Calliditas Therapeutics AB ADR (CALT) Company Bio. Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. Next Event. Calliditas Therapeutics AB Annual Shareholders Meeting Jun 25, 2021 Total Debt To Equity (MRQ). 0.07.

November 8 2019. SEC CIK #0001795579 · – · Documents · Company Names & Stock Symbols · Where To Trade CALT · Latest USPTO Trademark Filings Calliditas Therapeutics is a specialty pharmaceutical company that develops pharmaceutical Stock Symbol NASDAQ:CALT; Company Type For Profit.
Phillipskurvan

marton lászló
competensum yrkeshögskola helsingborg
swedish air force
da rockwilder
revit autodesk requirements

Calliditas Therapeutics AB American Depositary Shares (CALT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

53.85%. Feb 28, 2021. false, Polar Capital Biotech S Inc, 1.00, 0.53.